Related Experiment Videos
Vasopressin: applications in clinical practice
Peter C Dyke1, Joseph D Tobias
1Department of Child Health, Division of Pediatric Critical Care/Pediatric Anesthesiology, University of Missouri-Columbia, MO 65212, USA.
Journal of Intensive Care Medicine
|August 7, 2004
Summary
Arginine vasopressin, a peptide hormone, is crucial for fluid balance. Emerging research highlights its therapeutic potential in treating cardiac arrest and vasodilatory shock in both adults and children.
Area of Science:
- Endocrinology
- Cardiovascular Physiology
- Nephrology
Background:
- Arginine vasopressin (AVP) is endogenously produced in the posterior pituitary.
- Its primary function involves regulating fluid homeostasis and osmolality.
- AVP plays a critical role in maintaining vascular tone.
Purpose of the Study:
- To review the fundamental physiology of arginine vasopressin.
- To examine the evidence supporting AVP's therapeutic use in critical care settings.
- To discuss the developing clinical applications of AVP.
Main Methods:
- Literature review of physiological studies on AVP.
- Analysis of clinical trial data for AVP in cardiac arrest and vasodilatory shock.
- Synthesis of current research on AVP's mechanism of action and efficacy.
Main Results:
- AVP is essential for maintaining blood pressure and fluid balance.
- Clinical studies show promising results for AVP in refractory vasodilatory shock.
- AVP administration has demonstrated benefits in certain cardiac arrest scenarios.
Conclusions:
- Arginine vasopressin is a vital hormone with expanding therapeutic applications.
- Its role in managing critical cardiovascular conditions is increasingly recognized.
- Further research is warranted to optimize AVP's clinical use.